Similar cell killing data to that obtained using AR42 alone or in combination with pazopanib in melanoma and ovarian cancer cells were also obtained using the generic pan-HDAC inhibitor sodium valproate (Supplementary Figure 2). Here, HDAC9 is linked to ovarian carcinoma.